NEW YORK (GenomeWeb) - Affymetrix reported after the close of the market Wednesday second quarter revenue growth of 4 percent, driven by increases in product revenues and in its genetic analysis business.

For the three months ended June 30, the company's revenues increased to $89 million from $85.4 million in the year-ago quarter. On a constant currency basis, its revenues increased almost 8 percent year over year, and beat the average Wall Street estimate of $88.6 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.